Clinical Trial Update: Importance of the Infusion Rate for the Plasma Expanding Effect of 5% Albumin in the Septic Patient [Phase 4]

View source ↗

Summary

A phase 4 clinical trial update highlights how the rate of infusion influences the plasma-expanding effect of 5% albumin in septic patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Albumin 5% solution (Human serum albumin 5% solution)

Snippet

Sponsor: Hainan People's Hospital | Conditions: Sepsis | Phase 4 | Status: UNKNOWN